Validation of UCSD-Mayo Risk Score for Predicting Hospital-Acquired AKI in COVID-19 Patients

dc.contributor.authorRolando Claure‐Del Granado
dc.contributor.authorNicholas Yuri Barbosa
dc.contributor.authorMarina Wainstein
dc.contributor.authorSally Shrapnel
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:17:23Z
dc.date.available2026-03-22T19:17:23Z
dc.date.issued2022
dc.identifier.doi10.1681/asn.20223311s1334c
dc.identifier.urihttps://doi.org/10.1681/asn.20223311s1334c
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/75175
dc.language.isoen
dc.publisherAmerican Society of Nephrology
dc.relation.ispartofJournal of the American Society of Nephrology
dc.sourceUniversity of San Simón
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectMedicine
dc.subject2019-20 coronavirus outbreak
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectInternal medicine
dc.titleValidation of UCSD-Mayo Risk Score for Predicting Hospital-Acquired AKI in COVID-19 Patients
dc.typearticle

Files